Surface functionalization of magnetic iron oxide nanoparticles for MRI applications - effect of anchoring group and ligand exchange protocol

Contrast Media and Molecular Imaging

Volumn 6, Issue 4, 2011, Pages 189-199

  Smolensky, Eric D ^a   Park, Hee Yun E ^a   Berquó, Thelma S ^a   Pierre, Valérie C ^a  

^a University of Minnesota   (United States)

Author keywords

Contrast agent; Iron oxide nanoparticles; Magnetism; MION; MRI; Relaxivity; Superparamagnetic agents; Surface functionalization

Indexed keywords

2,3 DIHYDROXYBENZAMIDE; CARBOXYLIC ACID; CATECHOL; CONTRAST MEDIUM; IRON OXIDE; MACROGOL; MAGNETITE NANOPARTICLE; METAL OXIDE; NANOPARTICLE; OLEIC ACID; PHOSPHONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CLINICAL PROTOCOL; CONTROLLED STUDY; CRYSTAL STRUCTURE; HYDROPHILICITY; HYSTERESIS; MAGNETISM; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RELAXIVITY; SURFACE PROPERTY; TRANSMISSION ELECTRON MICROSCOPY; X RAY DIFFRACTION;

CONTRAST MEDIA; FERRIC COMPOUNDS; MAGNETIC RESONANCE IMAGING; MAGNETICS; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; NANOTECHNOLOGY;

EID: 80051936886     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.417     Document Type: Article

References (36)

1. Cheon J, Lee J-H. Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology. Acc Chem Res 2008; 41: 1630-1640.
2. Di Marco M, Sadun C, Port M, Guilbert I, Couvreur P, Dubernet C. Physicochemical characterization of ultrasmall superparamagnetic iron oxide particles (USPIO) for biomedical application as MRI contrast agents. Int J Nanomed 2007; 2: 609-622.
3. Laurent S, Forge D, Port M, Roch A, Robic C, Vander Elst L, Muller RN. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 2008; 108: 2064-2110.
4. Muller RN, Roch A, Colet J-M, Ouakssim A, Gillis P. Particulate magnetic contrast agents. In The Chemistry of Contrast Agents, Merbach AE, Tóth E (eds). Wiley: Chichester, 2001.
5. Jung CW, Jacobs P. Physical and chemical-properties of superparamagnetic iron-oxide MR contrast agents - ferumoxides, ferumoxtran, ferumoxsil. Magn Reson Imag 1995; 13: 661-674.
6. 3+ complexes of interest in magnetic resonance imaging: an integrated and theoretically self consistent approach. J Am Chem Soc 1996; 118: 9333-9346.
7. Toth E, Helm L, Merbach AE. Relaxivity of MRI contrast agents. Top Curr Chem 2002; 221: 61-101.
8. Caravan P, Ellison JJ, McMurry TJ, Lauffer RB. Gadolinium(III) chelates as MRI contrast agents: structure, dynamics, and applications. Chem Rev 1999; 99: 2293-2352.
9. Geraldes CFGC, Laurent S. Classification and basic properties of contrast agents for magnetic resonance imaging. Contrast Media Mol Imag 2009; 4: 1-23.
10. Chan KWY, Wong WT. Small molecular gadolinium(III) complexes as MRI contrast agents for diagnostic imaging. Coord Chem Rev 2007; 251: 2428-2451.
11. Roch A, Muller RN, Gillis P. Theory of proton relaxation induced by superparamagnetic particles. J Chem Phys 1999; 110: 5403-5411.
12. Ouakssim A, Fastrez S, Roch A, Laurent S, Gossuin Y, Piérart C, Vander Elst L, Muller RN. Control of the synthesis of magnetic fluids by relaxometry and magnetometry. J Magn Magn Mater 2004; 272-276: E1711-E1713.
13. Roch A, Gillis P, Ouakssim A, Muller RN. Proton magnetic relaxation in superparamagnetic aqueous colloids: a new tool for the investigation of ferrite crystal anisotropy. J Magn Magn Mater 1999; 201: 77-79.
14. Bulte JWM, Brooks RA, Moskowitz BM, Henry Bryant JL, Frank JA. T1 and T2 relaxometry of monocrystalline iron oxide nanoparticles (MION-46L): theory and experiment. Acad Radiol 1998; 5: S137-S140.
15. Roch A, Muller RN, Gillis P. Water relaxation by SPM particles: neglecting the magnetic anisotropy? A caveat. J Magn Reson Imag 2001; 14: 94-96.
16. Park J, An K, Hwang Y, Park J-G, Noh H-J, Kim J-Y, Park J-H, Hwang N-M, Hyeon T. Ultra-large-scale syntheses of monodisperse nanocrystals. Nat Mater 2004; 3: 891-895.
17. 3 nanoparticles. Chem Mater 1999; 11: 3058-3064.
18. Wu W, He QG, Jiang CZ. Magnetic iron oxide nanoparticles: synthesis and surface functionalization strategies. Nano Res Lett 2008; 3: 397-415.
19. Yee C, Kataby G, Ulman A, Prozorov T, White H, King A, Rafailovich M, Sokolov J, Gedanken A. Self-assembled monolayers of alkanesulfonic and -phosphonic acids on amorphous iron oxide nanoparticles. Langmuir 1999; 15: 7111-7115.
20. Sahoo Y, Pizem H, Fried T, Golodnitsky D, Burstein L, Sukenik CN, Markovich G. Alkyl phosphonate/phosphate coating on magnetite nanoparticles: a comparison with fatty acids. Langmuir 2001; 17: 7907-7911.
21. Daou TJ, Grenèche JM, Pourroy G, Buathong S, Derory A, Ulhaq-Bouillet C, Donnio B, Guillon D, Begin-Colin S. Coupling agent effect on magnetic properties of functionalized magnetite-based nanoparticles. Chem Mater 2008; 20: 5869-5875.
22. Herea DD, Chiriac H. One-step preparation and surface activation of magnetic iron oxide nanoparticles for bio-medical applications. Optoelectron Adv Mater 2008; 2: 549-552.
23. Xu C, Xu K, Gu H, Zheng R, Liu H, Zhang X, Guo Z, Xu B. Dopamine as a robust anchor to immobilize functional molecules on the iron oxide shell of magnetic nanoparticles. J Am Chem Soc 2004; 126: 9938-9939.
24. Shultz MD, Reveles JU, Khanna SN, Carpenter EE. Reactive nature of dopamine as a surface functionalization agent in iron oxide nanoparticles. J Am Chem Soc 2007; 129: 2482-2487.
25. Sun SH, Zeng H, Robinson DB, Raoux S, Rice PM, Wang SX, Li GX. Monodisperse MFe2O4 (M=Fe, Co, Mn) nanoparticles. J Am Chem Soc 2004; 126: 273-279.
26. 4) nanoparticles without surfactants at room temperature. Mater Lett 2007; 61: 4447-4451.
27. Balasubramanian S, Xuefei H. Functionalization of magnetic nanoparticles with organic molecules: loading level determination and evaluation of linker length effect on immobilization. Chirality 2008; 20: 265-277.
28. Patterson AL. The Scherrer formula for X-ray particle size determination. Phys Rev 1939; 56: 978-982.
29. Weissleder R, Elizondo G, Wittenberg J, Rabito CA, Bengele HH, Josephson L. Ultrasmall superparamagnetic iron-oxide - characterization of a new class of contrast agents for mr imaging. Radiology 1990; 175: 489-493.
30. Young-wook J, Jae-Hyun L, Jinwoo C. Chemical design of nanoparticle probes for high-performance magnetic resonance imaging. Angew Chem., Int Ed Engl 2008; 47: 5122-5135.
31. Goya GF, Berquo TS, Fonseca FC, Morales MP. Static and dynamic magnetic properties of spherical magnetite nanoparticles. J Appl Phys 2003; 94: 3520-3528.
32. Hadjipanayis G, Sellmyer DJ, Brandt B. Rare-earth rich metallic glasses. 1. Magnetic hysteresis. J Phys Rev B 1981; 23: 3349-3354.
33. Herea DD, Chiriac H. One-step preparation and surface activation of magnetic iron oxide nanoparticles for bio-medical applications. Optoelectron Adv Mater 2008; 2: 549-552.
34. Daou TJ, Grenèche JM, Pourroy G, Buathong S, Derory A, Ulhaq-Bouillet C, Donnio B, Guillon D, Begin-Colin S. Coupling agent effect on magnetic properties of functionalized magnetite-based nanoparticles. Chem Mater 2008; 20: 5869-5875.
35. El Ayaan U, Herlinger E, Jameson RF, Linert W. Anaerobic oxidation of dopamine by iron(III). J Chem Soc, Dalton Trans 1997; 2813-2818.
36. Rohrer M, Bauer H, Mintorovitch J, Requardt M, Weinmann H-J. Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths. Invest Radiol 2005; 40: 715-724.